37 related articles for article (PubMed ID: 12935424)
1. Inhibiting severe acute respiratory syndrome-associated coronavirus by small interfering RNA.
Zhang R; Guo Z; Lu J; Meng J; Zhou C; Zhan X; Huang B; Yu X; Huang M; Pan X; Ling W; Chen X; Wan Z; Zheng H; Yan X; Wang Y; Ran Y; Liu X; Ma J; Wang C; Zhang B
Chin Med J (Engl); 2003 Aug; 116(8):1262-4. PubMed ID: 12935424
[TBL] [Abstract][Full Text] [Related]
2. Small molecules targeting severe acute respiratory syndrome human coronavirus.
Wu CY; Jan JT; Ma SH; Kuo CJ; Juan HF; Cheng YS; Hsu HH; Huang HC; Wu D; Brik A; Liang FS; Liu RS; Fang JM; Chen ST; Liang PH; Wong CH
Proc Natl Acad Sci U S A; 2004 Jul; 101(27):10012-7. PubMed ID: 15226499
[TBL] [Abstract][Full Text] [Related]
3. The life cycle of SARS coronavirus in Vero E6 cells.
Qinfen Z; Jinming C; Xiaojun H; Huanying Z; Jicheng H; Ling F; Kunpeng L; Jingqiang Z
J Med Virol; 2004 Jul; 73(3):332-7. PubMed ID: 15170625
[TBL] [Abstract][Full Text] [Related]
4. RNA Interference Approach Is a Good Strategy against SARS-CoV-2.
Lee YR; Tsai HP; Yeh CS; Fang CY; Chan MWY; Wu TY; Shen CH
Viruses; 2022 Dec; 15(1):. PubMed ID: 36680140
[TBL] [Abstract][Full Text] [Related]
5. Antisense technology as a potential strategy for the treatment of coronaviruses infection: With focus on COVID-19.
Alavizadeh SH; Doagooyan M; Zahedipour F; Torghabe SY; Baharieh B; Soleymani F; Gheybi F
IET Nanobiotechnol; 2022 May; 16(3):67-77. PubMed ID: 35274474
[TBL] [Abstract][Full Text] [Related]
6. Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV).
Tong TR
Perspect Med Virol; 2006; 16():43-95. PubMed ID: 32287586
[TBL] [Abstract][Full Text] [Related]
7. RNA interference-mediated silencing of the respiratory syncytial virus nucleocapsid defines a potent antiviral strategy.
Alvarez R; Elbashir S; Borland T; Toudjarska I; Hadwiger P; John M; Roehl I; Morskaya SS; Martinello R; Kahn J; Van Ranst M; Tripp RA; DeVincenzo JP; Pandey R; Maier M; Nechev L; Manoharan M; Kotelianski V; Meyers R
Antimicrob Agents Chemother; 2009 Sep; 53(9):3952-62. PubMed ID: 19506055
[TBL] [Abstract][Full Text] [Related]
8. Application of siRNA against SARS in the rhesus macaque model.
Tang Q; Li B; Woodle M; Lu PY
Methods Mol Biol; 2008; 442():139-58. PubMed ID: 18369784
[TBL] [Abstract][Full Text] [Related]
9. Severe acute respiratory syndrome coronavirus as an agent of emerging and reemerging infection.
Cheng VC; Lau SK; Woo PC; Yuen KY
Clin Microbiol Rev; 2007 Oct; 20(4):660-94. PubMed ID: 17934078
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic and prophylactic potential of small interfering RNAs against severe acute respiratory syndrome: progress to date.
Chang Z; Babiuk LA; Hu J
BioDrugs; 2007; 21(1):9-15. PubMed ID: 17263585
[TBL] [Abstract][Full Text] [Related]
11. Antiviral applications of RNAi for coronavirus.
Wu CJ; Chan YL
Expert Opin Investig Drugs; 2006 Feb; 15(2):89-97. PubMed ID: 16433589
[TBL] [Abstract][Full Text] [Related]
12. Using siRNA in prophylactic and therapeutic regimens against SARS coronavirus in Rhesus macaque.
Li BJ; Tang Q; Cheng D; Qin C; Xie FY; Wei Q; Xu J; Liu Y; Zheng BJ; Woodle MC; Zhong N; Lu PY
Nat Med; 2005 Sep; 11(9):944-51. PubMed ID: 16116432
[TBL] [Abstract][Full Text] [Related]
13. RNA interference: from gene silencing to gene-specific therapeutics.
Leung RK; Whittaker PA
Pharmacol Ther; 2005 Aug; 107(2):222-39. PubMed ID: 15908010
[TBL] [Abstract][Full Text] [Related]
14. Development of antiviral therapy for severe acute respiratory syndrome.
Cinatl J; Michaelis M; Hoever G; Preiser W; Doerr HW
Antiviral Res; 2005 Jun; 66(2-3):81-97. PubMed ID: 15878786
[TBL] [Abstract][Full Text] [Related]
15. Treatment and vaccines for severe acute respiratory syndrome.
Groneberg DA; Poutanen SM; Low DE; Lode H; Welte T; Zabel P
Lancet Infect Dis; 2005 Mar; 5(3):147-55. PubMed ID: 15766649
[TBL] [Abstract][Full Text] [Related]
16. From genome to antivirals: SARS as a test tube.
Kliger Y; Levanon EY; Gerber D
Drug Discov Today; 2005 Mar; 10(5):345-52. PubMed ID: 15749283
[TBL] [Abstract][Full Text] [Related]
17. Immune responses with DNA vaccines encoded different gene fragments of severe acute respiratory syndrome coronavirus in BALB/c mice.
Wang Z; Yuan Z; Matsumoto M; Hengge UR; Chang YF
Biochem Biophys Res Commun; 2005 Feb; 327(1):130-5. PubMed ID: 15629440
[TBL] [Abstract][Full Text] [Related]
18. Clinical picture, diagnosis, treatment and outcome of severe acute respiratory syndrome (SARS) in children.
Leung CW; Chiu WK
Paediatr Respir Rev; 2004 Dec; 5(4):275-88. PubMed ID: 15531251
[TBL] [Abstract][Full Text] [Related]
19. RNA interference: a potent tool for gene-specific therapeutics.
Ichim TE; Li M; Qian H; Popov IA; Rycerz K; Zheng X; White D; Zhong R; Min WP
Am J Transplant; 2004 Aug; 4(8):1227-36. PubMed ID: 15268723
[TBL] [Abstract][Full Text] [Related]
20. RNA silencing of rotavirus gene expression.
Arias CF; Dector MA; Segovia L; López T; Camacho M; Isa P; Espinosa R; López S
Virus Res; 2004 Jun; 102(1):43-51. PubMed ID: 15068879
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
